Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0A6R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,640
Award facts
- Contract value 100% obligated
- $16,639.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $16,639.53, was awarded on January 29, 2026, to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens. The Defense Logistics Agency, the funding federal agency, issued this competitively awarded, firm fixed-price contract with an ultimate completion date of January 30, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Dupixent is a biologic medication used to treat moderate to severe atopic dermatitis, asthma, and other inflammatory conditions, making this delivery order part of DLA's broader mission to supply essential pharmaceutical commodities to military treatment facilities and veterans' healthcare programs. The non-set-aside designation indicates this award was made through open and full competition. AmerisourceBergen's extensive portfolio of federal contracts demonstrates the company's established capability to efficiently fulfill government pharmaceutical procurement requirements across multiple therapeutic domains and support the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0A6R?
SPE2DR26F0A6R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F0A6R worth?
The government has obligated $16,640 on SPE2DR26F0A6R.
Is contract SPE2DR26F0A6R an order under another contract?
Yes. SPE2DR26F0A6R is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A6R competed?
The extent of competition for SPE2DR26F0A6R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award